New Generation mRNA Booster Vaccine Against Emerging VOCs
NCT05580159
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
2000
Enrollment
INDUSTRY
Sponsor class
Conditions
Immunogenicity
Efficacy
Safety
Interventions
BIOLOGICAL:
SW-BIC-213
BIOLOGICAL:
SARS-Cov-2 Vaccina(Vero Cell ) Inactivated
Sponsor
Stemirna Therapeutics